Title:
【発明の名称】ST1435の治療有効局所施用
Document Type and Number:
Japanese Patent JP2625254
Kind Code:
B2
Abstract:
16-methylene-17 alpha -acetoxy-19-nopregnene-3,20-dione (ST1435) can be formulated for hormonal therapy by transdermal application to provide sustained blood release through the skin into the blood so as to provide pharmaceutically effective serum levels of ST1435 without occluding the skin.
More Like This:
JPH08169819 | STRIP FIXING BASE |
JP7366166 | patch |
WO/2014/078832 | IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS OF TREATMENT THEREOF |
Inventors:
Mu-Young, Alfred
Zepeda-Ortega, Ana
Croxat, Horacio Brno
Zepeda-Ortega, Ana
Croxat, Horacio Brno
Application Number:
JP51121391A
Publication Date:
July 02, 1997
Filing Date:
May 24, 1991
Export Citation:
Assignee:
The Population Council
International Classes:
A61K9/70; A61K31/57; A61K47/00; A61P5/30; A61K9/00; A61P15/00; A61P15/18; C07J5/00; (IPC1-7): A61K31/57; A61K9/00; A61K9/70
Other References:
【文献】米国特許4292965(US,A)
【文献】Chemical Abstruots 102:179266(1985)
【文献】Chemical Abstruots 102:179266(1985)
Attorney, Agent or Firm:
Akira Asamura (3 outside)